NeoPhore's Corporate Minority Round

NeoPhore raised a round of funding on November 15, 2017. Investors include Sixth Element Capital.

NeoPhore is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system.…

Articles about NeoPhore's Corporate Minority Round: